• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Obinutuzumab

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO SymbolReferenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
ObinutuzumabOncologyMS4A1
CD20 positive
Indication and Usage, Warnings and Precautions, Description, Clinical Pharmacology, Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling